| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Interest income: |
| Interest income on loans | 95.7 | 88.7 | 82.6 | 80.7 | 81.5 | 83.6 | 87.0 | 88.0 |
| Interest income on investments | 11.0 | 10.9 | 10.5 | 9.7 | 9.0 | 8.3 | 7.7 | 7.2 |
| | 109.8 | 102.9 | 96.0 | 93.2 | 92.4 | 93.0 | 95.8 | 96.1 |
| Interest expense: |
| Interest on deposits | 12.4 | 6.5 | 3.6 | 2.6 | 2.7 | 2.9 | 3.6 | 4.8 |
| | 17.1 | 9.9 | 5.8 | 4.2 | 4.2 | 4.6 | 5.4 | 6.7 |
| Net interest income | 92.7 | 93.0 | 90.2 | 89.1 | 88.1 | 88.4 | 90.4 | 70.1 |
| Net interest income after provision for loan losses | 92.7 | 93.0 | 90.2 | 89.1 | 88.1 | 88.4 | 90.4 | 70.1 |
| Other non-interest income | 17.1 | 17.6 | 18.8 | 20.0 | 20.4 | 20.7 | 21.0 | 20.4 |
| Total non-interest income | 17.1 | 17.6 | 18.8 | 20.0 | 20.4 | 20.7 | 21.0 | 20.4 |
| Non-interest expenses | 65.1 | 64.4 | 64.1 | 62.7 | 61.1 | 60.3 | 59.0 | 58.2 |
| Pre-tax income before non-recurring items | 42.0 | 43.2 | 43.1 | 47.5 | 48.6 | 51.6 | 54.4 | 51.3 |
| Non-recurring items | -0.3 | -0.3 | -0.2 | -0.4 | -0.5 | -0.8 | -0.9 | -0.6 |
| Pre-tax income | 42.3 | 43.5 | 43.4 | 47.9 | 49.1 | 52.4 | 55.2 | 51.9 |
| Income taxes | 8.7 | 8.9 | 8.9 | 10.2 | 10.5 | 11.2 | 11.7 | 10.9 |
| Tax rate | 20.6% | 20.5% | 20.6% | 21.3% | 21.3% | 21.3% | 21.2% | 21.0% |
| Net income | 33.6 | 34.6 | 34.4 | 37.7 | 38.6 | 41.2 | 43.5 | 41.0 |
| Net margin | 30.1% | 30.8% | 31.1% | 34.1% | 35.1% | 37.3% | 38.6% | 40.5% |
| |
| Basic EPS | $3.16 | $3.25 | $3.22 | $3.51 | $3.58 | $3.80 | $3.99 | $3.75 |
| Diluted EPS | $3.16 | $3.24 | $3.22 | $3.51 | $3.58 | $3.80 | $3.99 | $3.75 |
| |
| Shares outstanding (basic) | 10.6 | 10.7 | 10.7 | 10.7 | 10.8 | 10.8 | 10.9 | 10.9 |
| Shares outstanding (diluted) | 10.6 | 10.7 | 10.7 | 10.7 | 10.8 | 10.8 | 10.9 | 10.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |